株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

白内障:世界の治験レビュー

Cataract Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 237451
出版日 ページ情報 英文 163 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.92円で換算しております。
Back to Top
白内障:世界の治験レビュー Cataract Global Clinical Trials Review, H2, 2016
出版日: 2016年11月30日 ページ情報: 英文 163 Pages
概要

当レポートでは、世界各国における白内障治療薬の臨床試験について調査し、地域・進捗状況・フェーズ(相)・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、各企業・機関での進行状況といった情報を盛り込んで、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 白内障
    • レポートガイダンス
  • 臨床試験 地域別
    • 臨床試験 国別
    • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要5ヵ国 − 中東およびアフリカ
    • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験 相別
  • 臨床試験 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
  • 有望な治療薬比較
  • 主な治験参加企業
  • 臨床試験プロファイル
    • 臨床試験概要: 主要企業
      • Bausch & Lomb Incorporated
      • ISTA Pharmaceuticals, Inc.
      • Innovative Medical Products
      • Alcon Research Ltd.
      • Bucci Laser Vision
      • Omeros Corporation
      • Alcon, Inc.
      • Allergan, Inc.
      • Aurolab
      • LABORATOIRES THEA
      • InSite Vision Incorporated
      • The Chakshu Research, Inc.
      • Aqumen Biopharmaceuticals
      • Bp Consulting Inc
      • ESBATech AG
      • 千寿製薬
      • Transcend Services, Inc.
      • Novartis AG
      • Acucela Inc.
      • Dean Health Systems, Inc.
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • Iladevi Cataract and IOL Research Center
      • Medical University of South Carolina
      • The Wenzhou Medical College
      • Indiana University School of Medicine
      • Veroia General Hospital
      • Federal University of Sao Paulo
      • Johns Hopkins University
      • Karolinska Institutet
      • Sheba Medical Center
      • Sun Yat-sen University
      • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
      • University of Sao Paulo
      • Carmel Medical Center
      • Frederiksberg Hospital
      • Hospital Hietzing
      • Dr. Ram Manohar Lohia Hospital
      • Samsung Medical Center
      • Tabriz University
      • Chulalongkorn University
      • Medical University of Vienna
  • 主要5件の臨床プロファイル
  • 付録

    図表一覧


    このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

    目次
    Product Code: GDHC3968CTIDB

    GlobalData's clinical trial report, "Cataract Global Clinical Trials Review, H2, 2016" provides an overview of Cataract clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

    The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

    Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Scope

    • The report provides a snapshot of the global clinical trials landscape
    • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    • The Report provides enrollment trends for the past five years
    • Report provides latest news for the past three months

    Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Reasons to buy

    • Assists in formulating key business strategies with regards to investment
    • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
    • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
    • Supports understanding of trials count and enrollment trends by country in global therapeutics market
    • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    • Facilitates clinical trial assessment of the indication on a global, regional and country level

    Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

    Table of Contents

    Table of Contents

    Table of Contents 2

    • List of Tables 3
    • List of Figures 4
    • Report Guidance 5
    • Clinical Trials by Region 6
    • Clinical Trials and Average Enrollment by Country 7
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
    • Top Five Countries Contributing to Clinical Trials in Europe 10
    • Top Countries Contributing to Clinical Trials in North America 11
    • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
    • Top Countries Contributing to Clinical Trials in Central and South America 13
    • Clinical Trials by G7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials 14
    • Clinical Trials by Phase in G7 Countries 15
    • Clinical Trials in G7 Countries by Trial Status 16
    • Clinical Trials by E7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials 17
    • Clinical Trials by Phase in E7 Countries 18
    • Clinical Trials in E7 Countries by Trial Status 19
    • Clinical Trials by Phase 20
    • In Progress Trials by Phase 21
    • Clinical Trials by Trial Status 22
    • Clinical Trials by End Point Status 23
    • Subjects Recruited Over a Period of Time 24
    • Clinical Trials by Sponsor Type 25
    • Prominent Sponsors 26
    • Top Companies Participating in Cataract Therapeutics Clinical Trials 27
    • Prominent Drugs 29
    • Clinical Trial Profile Snapshots 30

    Appendix 160

    • Abbreviations 160
    • Definitions 160
    • Research Methodology 161
    • Secondary Research 161
    • About GlobalData 162
    • Contact Us 162
    • Disclaimer 162
    • Source 163

    List of Tables

    List of Tables

    • Cataract Therapeutics, Global, Clinical Trials by Region, 2016* 6
    • Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
    • Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
    • Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
    • Cataract Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
    • Cataract Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
    • Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
    • Cataract Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
    • Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
    • Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
    • Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
    • Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
    • Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
    • Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
    • Cataract Therapeutics, Global, Clinical Trials by Phase, 2016* 20
    • Cataract Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
    • Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
    • Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
    • Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
    • Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
    • Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
    • Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
    • Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

    List of Figures

    List of Figures

    • Cataract Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
    • Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
    • Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
    • Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
    • Cataract Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
    • Cataract Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
    • Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
    • Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
    • Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
    • Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
    • Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
    • Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
    • Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
    • Cataract Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
    • Cataract Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
    • Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
    • Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
    • Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
    • Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
    • Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
    • Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
    • Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
    • GlobalData Methodology 161
    Back to Top